Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Thiamine + pyridoxine is an oral combination of two water-soluble B vitamins, vitamin B1 (thiamine) and vitamin B6 (pyridoxine), used primarily as a nutritional supplement and as an adjunct in conditions associated with B-vitamin deficiency, including neuropathic symptoms. Thiamine is phosphorylated intracellularly to thiamine pyrophosphate, a cofactor for enzymes in carbohydrate metabolism and neuronal energy production, while pyridoxine is converted to pyridoxal 5′-phosphate, a cofactor for numerous enzymes involved in amino acid metabolism, neurotransmitter synthesis (including GABA, serotonin, and dopamine), and sphingolipid biosynthesis. At pharmacologic doses, these vitamins may exert additional neurotropic and analgesic-modulating effects, including influences on inflammatory pathways, ion channels, and neurotransmission, making them useful as supportive therapy in neuropathic and musculoskeletal pain when combined with other agents.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on thiamine + pyridoxine.